.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Deloitte
Baxter
Queensland Health
Fuji
Cantor Fitzgerald
Dow
Novartis
McKesson
Accenture

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090912

« Back to Dashboard
NDA 090912 describes ACARBOSE, which is a drug marketed by Strides Pharma, Watson Labs, Impax Labs, Virtus Pharm, Mylan, West-ward Pharms Int, and Emcure Pharms Ltd, and is included in seven NDAs. It is available from eleven suppliers. Additional details are available on the ACARBOSE profile page.

The generic ingredient in ACARBOSE is acarbose. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the acarbose profile page.

Summary for NDA: 090912

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 090912

Mechanism of Actionalpha Glucosidase Inhibitors

Suppliers and Packaging for NDA: 090912

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACARBOSE
acarbose
TABLET;ORAL 090912 ANDA Libertas Pharma, Inc. 51862-210 51862-210-01 100 TABLET in 1 BOTTLE, PLASTIC (51862-210-01)
ACARBOSE
acarbose
TABLET;ORAL 090912 ANDA Libertas Pharma, Inc. 51862-211 51862-211-01 100 TABLET in 1 BOTTLE, PLASTIC (51862-211-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Jul 27, 2011TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jul 27, 2011TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Jul 27, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Baxter
US Army
Chinese Patent Office
Cerilliant
Fuji
Colorcon
Merck
Deloitte
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot